hematoxylin has been researched along with Spinal Cord Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, H; Huang, N; Jin, Z; Kang, J; Ning, B; Pan, L; Tian, L; Zhang, X; Zhang, Y | 1 |
| Cao, J; Chang, J; Jiang, F; Qian, Z; Xia, M; Yang, L; Zhang, Y; Zhang, Z | 1 |
2 other study(ies) available for hematoxylin and Spinal Cord Injuries
| Article | Year |
|---|---|
Apigenin inhibits fibrous scar formation after acute spinal cord injury through TGFβ/SMADs signaling pathway.
Topics: Actins; Animals; Apigenin; Cicatrix; Collagen; Eosine Yellowish-(YS); Fibronectins; Hematoxylin; Mice; Nerve Growth Factors; Recovery of Function; Signal Transduction; Spinal Cord; Spinal Cord Injuries; Transforming Growth Factor beta | 2022 |
Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury.
Topics: Animals; Autophagy; Autophagy-Related Proteins; Endocannabinoids; Eosine Yellowish-(YS); Hematoxylin; Inflammasomes; Inflammation; Interleukin-6; Lipopolysaccharides; Mice; Microtubule-Associated Proteins; Neuroinflammatory Diseases; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Cannabinoid; Spinal Cord Injuries | 2022 |